Randomized phase III study of Standard CHOP(S-CHOP) versus Biweekly CHOP(Bi-CHOP) in aggressive Non-Hodgkin's Lymphoma(JCOG9809)
Phase 3
- Conditions
- on-Hodgkin's lymphoma
- Registration Number
- JPRN-C000000036
- Lead Sponsor
- Japan Clinical Oncology Group(JCOG)
- Brief Summary
See the datails via "URL releasing results" above. Also the details can be seen in the JCOG website: http://www.jcog.jp/en/trials/index.html
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 450
Inclusion Criteria
Not provided
Exclusion Criteria
(1)uncontrolable diabetes mellitus (2)severe complication (infection, heart failure, renal failure, liver failure, etc) (3)anamnesis of heart disease (4)acute or chronic hepatitis, liver chirrosis and portal hypertension (5)synchronous or metachronous malignancy (6)sever plumonary dysfunction (7)CNS invasion (8)HIV positive (9)HBs-Ag positive (10)HCV-Ab positive
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Progression free survival
- Secondary Outcome Measures
Name Time Method overall survival, complete remission rate, toxicity